SEC Form 4 · accession 0001104659-15-042500
Vitae Pharmaceuticals, Inc · VTAE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Bryan E Roberts
Director
Period of report
May 28, 2015
Accepted (ET)
Jun 1, 2015 · 4:41 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001157602
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F2,F1 | $12.43 | May 28, 2015 | A | 10,000 | A | — | May 27, 2025 | Common Stock | 10,000 | 10,000 | D |
Explanation of responses
- F1The option will vest in equal quarterly installments over one year of service following the grant date.
- F2The reporting person is a member of VR Management, LLC (the "Management Company"). Under an agreement between the reporting person and the Management Company, the reporting person is deemed to hold the reported securities for the sole benefit of the Management Company (the "Management Company Securities") and must hold or sell these Management Company Securities solely upon the direction of the Management Company. The Management Company may be deemed the indirect beneficial owner of these Management Company Securities, and the reporting person may be deemed the indirect beneficial owner of these Management Company Securities through his interest in the Management Company. The reporting person disclaims beneficial ownership of these Management Company Securities except to the extent of his indirect pecuniary interest therein.